巴戟天挥发性成分研究

目的：研究巴戟天中的挥发性成分。方法：利用水蒸气蒸馏法提取巴戟天（Radix morindae offtcinalis）挥发油,用GC—MS进行测定,结合计算机检索技术对分离的化合物进行结构鉴定,应用色谱峰面积归一化法计算各成分的相对百分含量。结果：鉴定出34个化学成分,其中相对百分含量大于2％的分别确定为L-龙脑（Bomeol L）29．28％,α-姜烯（Alpha—Zingiberene）4．88％,2-甲基-6-对甲基苯基-2-庚烯（Ar-Cureumene）4．49％,1-己醇（1-Hexanol）3．40％,β-倍半水芹烯（beta—sesquiphellandrene）3．34％,2-戊基呋喃（2-Amylfuran）3．32％,正壬醛（n—nonanal）2．17％,樟脑（L—camphor）2．07％,β-没药烯（bete—Bisabolene）2．06％。结论：34个挥发性成分均为首次从该植物中得到。     

灵芝转化苦参水提物的3个新生成分体外抗乙型肝炎病毒作用

先在基础培养基中添加苦参水煎汁,然后培养灵芝,得到灵芝培养液,再按乙醇氯仿-5%碳酸氢钠溶液-氯仿的顺序提取培养液中的有机酸成分,用制备高效液相色谱分离,得到6个新组分,用这些组分分别作用于转染了乙型肝炎病毒DNA的2.2.15细胞,用固相放射免疫法测定细胞培养上清液中的乙肝病毒表面抗原(HBsAg)和e抗原(HBeAg)的含量,用四甲基偶氮唑盐(MTT)法测定细胞的存活率。结果表明,其中的3个组分对2.2.15细胞分泌HBsAg和HBeAg有抑制作用,提示可能具有抗乙肝病毒的作用。     

响应面法优化超声辅助提取太子参多糖工艺研究

本文探讨超声波作用下太子参多糖提取的最佳工艺条件。在单因素试验基础上,采用响应面法对太子参多糖提取工艺参数进行优化研究。响应面试验表明提取温度、提取时间和水料比对响应值多糖提取得率均有显著影响,优化得到太子参多糖超声提取最佳工艺条件为:提取温度为74℃;提取时间为65 min;水料比为26 mL/g;超声波功率100 W。在此条件下太子参多糖的提取得率为2.48%,与模型预测值非常接近。     

Comparative chemical profiling of three TCM drugs in the Paeoniaceae family by UPLC-MS/MS combined with chemometric methods

Paeoniae Radix Rubra (Chi-Shao in Chinese) and Paeoniae Radix Alba (Bai-Shao in Chinese) are two valuable traditional Chinese medicine (TCM) drugs, usually indicated for menstrual disorders and viral infections. Paeonia anomala subsp. anomala (Xinjiang-Shaoyao in Chinese) is taken as Chi-Shao substitute in Xinjiang, China. Due to the diverse growing conditions, there are some differences in chemical compositions of three TCM drugs. An UPLC fingerprint analysis with chemometric methods, including similarity analysis and hierarchical clustering analysis, was applied in the study. By virtue of UPLC-QTOF-MS, 29 components including 18 monoterpene glycosides, 5 galloyl glucoses and 6 phenolic compounds were simultaneously identified. It could be concluded that the UPLC-QTOF-MS combined with chemometric methods could efficiently identify the three TCM drugs, and was a powerful approach for the chemical profiling of three TCM drugs. The developed method provide an available approach for quality control of three TCM drugs.     

Two Radix spp. (Gastropoda: Lymnaeidae) endemic to thermal springs around Lake Baikal represent ecotypes of the widespread Radix auricularia

In this study, we re‐examine two species of freshwater gastropods of the genus Radix Montfort, 1810 (family Lymnaeidae), endemic to the geothermal springs in the Lake Baikal region in the southern part of eastern Siberia — Lymnaea (Radix) hakusyensis Kruglov et Starobogatov, 1989, and Lymnaea (Radix) thermobaicalica Kruglov et Starobogatov, 1989. The alleged species status of these endemics has been re‐assessed by means of an integrative approach combining molecular genetic taxonomy techniques with the traditional methods based on shell and soft body morphology. Phylogenetic reconstructions were made using both mitochondrial (COI) and nuclear (ITS2) DNA markers. We used topotypic samples of both species and specimens sampled from other sites around Lake Baikal. The results demonstrate that the two endemic species are only synonyms of a widespread Holarctic species, Radix auricularia (Linnaeus, 1758), and represent its intraspecific morph (ecotype) adapted to living in thermal springs. A new synonymy is proposed: Thermoradix Kruglov et Starobogatov, 1989 = Radix Montfort, 1810 (syn. n.).     

川乌植物内生真菌抗菌活性的研究

从川乌（Radix aconiti）植物的根和茎中分离获得内生真菌61株,经显微形态观察进行内生真菌的分类鉴定,同时采用纸片法进行抗菌活性筛选。结果有29株内生真菌显示抗菌活性,占菌株数的47．54％;毛壳菌属是抗菌活性菌株的优势种属;活性高且抗菌谱广的菌株有3株,主要分布在毛壳菌属和束丝菌属。结果表明：川乌植物内生真菌中广泛分布着有抗菌活性的菌株。     

传统中药影响黏性放线菌对唾液获得性膜黏附的研究

目的：研究不同传统中药提取物对黏性放线菌在唾液获得性膜黏附的影响,进一步探讨中药防龋的可能机制。方法：采用唾液包被羟磷灰石（S－HA）形成实验性获得性膜的体外模式,以黏性放线菌作为实验菌株,用不同的药物提取物分别处理S－HA和菌细胞,观察细菌对SHA的黏附情况。结果：两组实验中三七均能抑制菌细胞对SHA的黏附,且随药物浓度的升高而逐渐增强。结论：三七等传统中药能有效抑制黏性放线菌对唾液获得性膜的早期黏附。     

Radix/Rhizoma Notoginseng extract (Sanchitongtshu) for ischemic stroke: A randomized controlled study

Agents of sanchi have been widely used as a complementary medicine for stroke in China. Sanchitongshu is a new Chinese patent medicine extracted from sanchi which has stronger anti-platelet activity than other agents of sanchi. Our aim was to investigate the synergistic action of low dose of aspirin combined with sanchitongshu capsule in the treatment of patients with light and moderate ischemic stroke in acute and subacute stages.This was a multi-center, double-blinded, randomized controlled clinical trial conducted in four hospitals in China from July 2004 to 2006. 140 patients of ischemic stroke in anterior cerebral circulation within 30 days of onset were enrolled. Participants were assigned either to receive aspirin (50 mg per day) and sanchitongshu capsule (200 mg three times a day) or aspirin (50 mg per day) and placebo capsule.Low dose of aspirin combined with sanchitongshu capsule significantly ameliorated neurological deficit (increased score of ESS: t = −5.02, p < 0.0001) and activities of daily living (increased score of BI: t = −2.4, p = 0.0178) after treatment compared with aspirin alone. Adverse reaction which occurred equally in both arms, was light to moderate and disappeared without special treatment.Sanchitongshu capsule, as a complementary medicine to aspirin, was effective in improving outcomes after ischemic stroke. It was a safe drug in our trial.